Deciding Among Therapies for Ovarian Cancer

In patients with advanced solid tumors, treatment with nemvaleukin with or without Keytruda demonstrated antitumor activity and tolerability.

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

Nine years as an ovarian cancer “lifer” yields these tips for surviving and thriving when there’s no end of treatment ahead.

Olympic gymnast, Shannon Miller, sat down with CURE® to discuss her experience with a rare type of ovarian cancer, and how her competitive mindset helped her through.

Treatment containing Recentin demonstrated clinical benefits, but it proves worse than the current standard care treatment.

Results from the RAMP 201 clinical trial are promising for patients with recurrent low-grade serous ovarian cancer.